<DOC>
	<DOCNO>NCT01087879</DOCNO>
	<brief_summary>The impact different administration rout hormonal contraceptive androgen secretion , glucose metabolism inflammation . A prospective randomize trial . The investigator assume , transdermal transvaginal hormonal contraception would less effect androgen level , glucose metabolism inflammatory marker oral contraceptive .</brief_summary>
	<brief_title>The Effect Hormonal Contraceptives Androgens Glucose Metabolism</brief_title>
	<detailed_description>45 patient recruit study . Each study group consist 15 woman ( age 20-35 year ) receive oral , transdermal transvaginal hormonal contraception continuously 9 week . The subject least 2 month wash period hormonal medication prior study . The measurement serum sample OGTT perform 9 week medication .</detailed_description>
	<mesh_term>Norelgestromin</mesh_term>
	<mesh_term>Norgestrel</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>healthy woman age 20 35 year regular menstruation use hormonal contraception two month washout period contraindication use hormonal contraception irregular menstruation smoke alcohol addiction pregnancy nurse hypersensitivity component product headache focal neurological symptom serious multiple risk factor artery disease undiagnosed abnormal genital bleeding impair glucose tolerance DMT2</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>oral glucose tolerance test</keyword>
	<keyword>hormonal contraception</keyword>
	<keyword>androgen</keyword>
	<keyword>crp</keyword>
</DOC>